| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/23/2009 | WO2009049405A1 Bilayer composition for the sustained release of acetaminophen and tramadol |
| 04/23/2009 | WO2009049365A1 A method of prophylaxis and agents for use therein |
| 04/23/2009 | WO2009049354A1 Controlled-release pharmaceutical formulation |
| 04/23/2009 | WO2009032246A3 Particulate compositions for delivery of poorly soluble drugs |
| 04/23/2009 | WO2009026414A3 Novel application of topical anesthetics for modulation of neurogenic tremor |
| 04/23/2009 | WO2009026257A3 Methods and compositions for controlling the bioavailability of poorly soluble drugs |
| 04/23/2009 | WO2009024686A3 Novel method for producing dry hydrodispersible pharmaceutical forms |
| 04/23/2009 | WO2009024670A3 Hyaluronic acid injectable gel for treating joint degeneration |
| 04/23/2009 | WO2009023803A3 Modulated release formulation for the delivery of one or more medicaments |
| 04/23/2009 | WO2009014441A3 Microparticles comprising pcl and uses thereof |
| 04/23/2009 | WO2008152347A3 Pack of medicinal tablets |
| 04/23/2009 | WO2008128775A3 Stabilised pharmaceutical composition containing pregabaline |
| 04/23/2009 | WO2008118331A3 Tablet formulations containing 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom |
| 04/23/2009 | WO2008107301A3 Rapid-disintegration monolayer film for the oral administration of active substances |
| 04/23/2009 | WO2008096377A3 Stable atorvastatin formulations |
| 04/23/2009 | WO2008068577A3 Pharmaceutical compositions |
| 04/23/2009 | WO2008068299A3 Hydrobromide salt of an anti-hiv compound |
| 04/23/2009 | WO2008065485A3 Stable pharmaceutical compositions of a calcium channel blocker and an ace inhibitor |
| 04/23/2009 | WO2008062273A3 Solid oral dosage form having antidiabetic drug combination |
| 04/23/2009 | WO2008057780A3 Transdermal delivery of ketoprofen polar derivatives |
| 04/23/2009 | WO2008047373A3 Device and method for patient activated bolus administration |
| 04/23/2009 | WO2008047239A3 Stable aerosol pharmaceutical formulations |
| 04/23/2009 | WO2008039186A3 Method and system for treatment of eating disorders |
| 04/23/2009 | WO2008001201A3 Pharmaceutical compositions of clopidogrel |
| 04/23/2009 | WO2007138577A3 Methods of generating a neural tissue using muscle-derived cells |
| 04/23/2009 | WO2007123511A3 Dosing regimens for the treatment of cancer |
| 04/23/2009 | WO2007099433A3 Delayed release dosage form of pantoprazole or salt thereof |
| 04/23/2009 | WO2007056501A3 Osmotic pump with remotely controlled osmotic pressure generation |
| 04/23/2009 | WO2007056432A3 Compositions for regulating intestinal disorders and methods of use thereof |
| 04/23/2009 | WO2007056424A3 Controlled-release emulsion compositions |
| 04/23/2009 | WO2007044902A3 Use of benzyl nicotinate for pain relief |
| 04/23/2009 | WO2007016128A3 Magnesium salt proton pump inhibitor dosage forms |
| 04/23/2009 | WO2007009089A3 Compositions containing flammulina velutipes extracts and methods for their administration |
| 04/23/2009 | WO2007001448A3 Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
| 04/23/2009 | WO2006102070A3 Sclerostin and the inhibition of wnt signaling and bone formation |
| 04/23/2009 | WO2006083874A3 Vaccine delivery compositions and methods of use |
| 04/23/2009 | WO2006076344A3 Ligand-mediated controlled drug delivery |
| 04/23/2009 | WO2006041942A3 Ocular delivery of polymeric delivery formulations |
| 04/23/2009 | WO2006033911A3 Methods of administering water-soluble prodrugs of propofol |
| 04/23/2009 | WO2006024039A3 Method for manufacturing of three dimensional composite surfaces for microarrays |
| 04/23/2009 | US20090106852 Influenza Therapeutic |
| 04/23/2009 | US20090105694 Medical or veterinary digestive tract utilization systems and methods |
| 04/23/2009 | US20090105667 Fluid medication delivery device |
| 04/23/2009 | US20090105351 Micellar drug delivery systems for hydrophobic drugs |
| 04/23/2009 | US20090105183 Pharmaceutical composition containing decoy and method of using the same |
| 04/23/2009 | US20090105126 Methods of Treating Pulmonary Disorders using Liposomal Vancomycin Formulations |
| 04/23/2009 | US20090104277 Preparation of Molecular Imprinted Polymers |
| 04/23/2009 | US20090104276 Faster absorption or hydrolysis, while preserving mechanical strength required for e.g. surgical sutures; also used to produce microspheres for use as an injectable composition or drug delivery carrier; copolymer of diglycolid acid, diethylene glycol, and a lactone |
| 04/23/2009 | US20090104275 Nanoencapsulation of Proteins |
| 04/23/2009 | US20090104274 Process of making microspheres |
| 04/23/2009 | US20090104273 Novel nifedipine compositions |
| 04/23/2009 | US20090104272 Inhaled hypertonic saline delivered by a heated nasal cannula |
| 04/23/2009 | US20090104271 Use of microparticles combined with submicron oil-in-water emulsions |
| 04/23/2009 | US20090104270 Film delivery system for tetrahydrolipstatin |
| 04/23/2009 | US20090104269 Nanoformulations |
| 04/23/2009 | US20090104268 Nanoparticles Comprising Antigens and Adjuvants, and Immunogenic Structures |
| 04/23/2009 | US20090104267 Soft tablet containing high molecular weight cellulosics |
| 04/23/2009 | US20090104266 3-(2-dimethylaminomethylcy clohexyl)phenol retard formulation |
| 04/23/2009 | US20090104265 Polymorphs of N-(4-chloro-3-methyl-5-isoxazolyl) 2-[2-methyl-4,5-(methylenedioxy)phenylacetyl] thiophene-3-sulfonamide, sodium salt |
| 04/23/2009 | US20090104264 Controlled release solid preparation |
| 04/23/2009 | US20090104263 5-HT4 partial agonist pharmaceutical compositions |
| 04/23/2009 | US20090104262 Chlorthalidone combinations |
| 04/23/2009 | US20090104261 Treatment for Attention-Deficit Hyperactivity Disorder |
| 04/23/2009 | US20090104260 Compositions and methods for sirna inhibition of icam-1 |
| 04/23/2009 | US20090104259 Compositions and methods for sirna inhibition of angiogenesis |
| 04/23/2009 | US20090104258 Use of tocopheryl phosphate as an agent for preventing or slowing down the appearance of the effects of skin ageing |
| 04/23/2009 | US20090104257 Liposomal Vancomycin Formulations |
| 04/23/2009 | US20090104256 Methods of Treating Pulmonary Disorders with Liposomal Amikacin Formulations |
| 04/23/2009 | US20090104255 Liposome Drug Delivery of Polycyclic, Aromatic, Antioxidant or Anti-Inflammatory Compounds |
| 04/23/2009 | US20090104254 Controlled Release Hydrogels |
| 04/23/2009 | US20090104253 Hemostatic biocidal dressing |
| 04/23/2009 | US20090104251 Heat stable microcapsules and methods for making and using the same |
| 04/23/2009 | US20090104249 Exotoxin Inhibitory Factor |
| 04/23/2009 | US20090104247 Coating Designs For The Tailored Release Of Dual Drugs From Polymeric Coatings |
| 04/23/2009 | US20090104243 Drug cores for sustained release of therapeutic agents |
| 04/23/2009 | US20090104237 Method for increasing tissue oxygenation |
| 04/23/2009 | US20090104236 Pharmaceutical solid hybrids |
| 04/23/2009 | US20090104235 Method for Producing of a Preparation of a Solid Dmso-Containing Silicone Oil Emulsion for the Binding of Reactive Oxygen Compounds in Human and Animal Bodies |
| 04/23/2009 | US20090104223 Method for Obtaining Antigenic Aggregates and the Use Thereof in Formulations |
| 04/23/2009 | US20090104127 Suspension aerosol formulations of pharmaceutical products |
| 04/23/2009 | US20090104126 Sulfamate Compounds and Uses Thereof |
| 04/23/2009 | US20090104125 Stable liquid desoximethasone compositions with reduced oxidized impurity |
| 04/23/2009 | US20090104117 Compositions and methods of use of targeting peptides against placenta and adipose tissues |
| 04/23/2009 | US20090104114 Nanotherapeutic Colloidal Metal Compositions and Methods |
| 04/23/2009 | DE112007001101T5 Bioelektromagnetisches Schnittstellensystem Bioelectromagnetic interface system |
| 04/23/2009 | DE102007050165A1 Stabilisierung von hydrophoben Proteintherapeutika Stabilization of hydrophobic protein therapeutics |
| 04/23/2009 | DE102007049931A1 Vorrichtung und Verfahren zur kontinuierlichen Herstellung von sphärischen Pulveragglomeraten Device and method for the continuous production of spherical powder agglomerates |
| 04/23/2009 | CA2703610A1 Manufacturing solid pharmaceutical dosage forms with visible micro- and nanostructured surfaces and micro- and nanostructured pharmaceutical dosage form |
| 04/23/2009 | CA2703579A1 Pharmaceutical moire pill |
| 04/23/2009 | CA2703002A1 Bowel purgative and uses thereof |
| 04/23/2009 | CA2702988A1 Functionalised materials and uses thereof |
| 04/23/2009 | CA2702935A1 Solid formulations of crystalline compounds |
| 04/23/2009 | CA2702904A1 Matrix-type pharmaceutical solid preparation |
| 04/23/2009 | CA2702903A1 Process for the modification of the solid state of a compound and co-amorphous compositions produced with same |
| 04/23/2009 | CA2702862A1 Cationic lipids |
| 04/23/2009 | CA2702688A1 Oral composition comprising a cooling agent |
| 04/23/2009 | CA2702664A1 Controlled-release pharmaceutical formulation |
| 04/23/2009 | CA2702614A1 Composition for administering an active ingredient and method for making and using the same |
| 04/23/2009 | CA2701761A1 Poly(urea-urethane) compositions useful as topical medicaments and methods of using the same |
| 04/23/2009 | CA2700818A1 Solvent-free synthesis of amphiphilic polymeric material |